Study protocol for a single-centre non-inferior randomised controlled trial on a novel three-dimensional matrix positioning-based cognitive fusion-targeted biopsy and software-based fusion-targeted biopsy for the detection rate of clinically significant prostate cancer in men without a prior biopsy

INTRODUCTION: The classical pathway for diagnosing prostate cancer is systematic 12-core biopsy under the guidance of transrectal ultrasound, which tends to underdiagnose the clinically significant tumour and overdiagnose the insignificant disease. Another pathway named targeted biopsy is using mult...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Biming, Li, Rongbing, Li, Dongyang, Huang, Liqun, Wen, Xiaofei, Yang, Guosheng, Wang, Haifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925935/
https://www.ncbi.nlm.nih.gov/pubmed/33550242
http://dx.doi.org/10.1136/bmjopen-2020-041427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925935/
https://www.ncbi.nlm.nih.gov/pubmed/33550242
http://dx.doi.org/10.1136/bmjopen-2020-041427

Ejemplares similares